C4 Therapeutics, Inc. (CCCC) Operating margin 2021–2025
C4 Therapeutics, Inc. (CCCC) operating margin by fiscal year — reported operating income divided by reported revenue.
-320.5%FY2025 · since FY2021: -179.4% → -320.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -320.5% | +15.6 pp |
| FY2024 | -336.1% | +333.7 pp |
| FY2023 | -669.8% | -253.3 pp |
| FY2022 | -416.6% | -237.2 pp |
| FY2021 | -179.4% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice